Ashok Verma

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. ncbi request reprint Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis
    Ashok Verma
    Department of Neurology, Kessenich Family MDA ALS Center, 1150 NW 14th Street, Suite 701, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
    Muscle Nerve 34:235-7. 2006
  2. doi request reprint Primary lateral sclerosis with HIV-1 infection
    Ashok Verma
    Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA
    Neurology 70:575-7. 2008
  3. pmc Altered RNA metabolism and amyotrophic lateral sclerosis
    Ashok Verma
    Department of Neurology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Ann Indian Acad Neurol 14:239-44. 2011
  4. ncbi request reprint RNA quality control and protein aggregates in amyotrophic lateral sclerosis: a review
    Ashok Verma
    Department of Neurology, University of Miami Miller School of Medicine, Clinical Research Building, 1120 NW 14 Street, Suite 1317, Miami, Florida 33136, USA
    Muscle Nerve 47:330-8. 2013
  5. doi request reprint Protein aggregates and regional disease spread in ALS is reminiscent of prion-like pathogenesis
    Ashok Verma
    Department of Neurology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Neurol India 61:107-10. 2013
  6. doi request reprint Induced pluripotent stem cells and promises of neuroregenerative medicine
    Ashok Verma
    University of Miami Miller School of Medicine, Miami, FL, USA
    Neurol India 59:555-7. 2011
  7. ncbi request reprint Epidemiology and clinical features of HIV-1 associated neuropathies
    A Verma
    Department of Neurology, University of Miami School of Medicine and Jackson Memorial Hospital, Florida, USA
    J Peripher Nerv Syst 6:8-13. 2001
  8. ncbi request reprint Opsoclonus-myoclonus syndrome following Epstein-Barr virus infection
    Ashok Verma
    Department of Neurology, University of Miami School of Medicine, FL 33136, USA
    Neurology 58:1131-2. 2002
  9. ncbi request reprint Isolated cerebral mucormycosis: report of a case and review of the literature
    Ashok Verma
    Department of Neurology, University of Miami School of Medicine, 1150 NW 14 Street, Suite 701, Miami, FL 33136, USA
    J Neurol Sci 240:65-9. 2006
  10. ncbi request reprint ALS syndrome in patients with HIV-1 infection
    Ashok Verma
    Department of Neurology, Kessenich Family MDA ALS Center, University of Miami Miller School of Medicine, 1150 NW 14 Street, Suite 701, Miami, FL 33136, USA
    J Neurol Sci 240:59-64. 2006

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis
    Ashok Verma
    Department of Neurology, Kessenich Family MDA ALS Center, 1150 NW 14th Street, Suite 701, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
    Muscle Nerve 34:235-7. 2006
    ..No major adverse effects were noted. Local injection of a small dose of Botox into the parotid glands can control sialorrhea and potentially improve living quality in some patients with bulbar ALS...
  2. doi request reprint Primary lateral sclerosis with HIV-1 infection
    Ashok Verma
    Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA
    Neurology 70:575-7. 2008
  3. pmc Altered RNA metabolism and amyotrophic lateral sclerosis
    Ashok Verma
    Department of Neurology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Ann Indian Acad Neurol 14:239-44. 2011
    ..This article reviews the current direction of research efforts toward understanding the role of RNA (ribonucleic acid) processing regulation in ALS and possible therapeutic pathways in this fatal disease...
  4. ncbi request reprint RNA quality control and protein aggregates in amyotrophic lateral sclerosis: a review
    Ashok Verma
    Department of Neurology, University of Miami Miller School of Medicine, Clinical Research Building, 1120 NW 14 Street, Suite 1317, Miami, Florida 33136, USA
    Muscle Nerve 47:330-8. 2013
    ..This article reviews the current research efforts toward understanding the role of RNA-processing regulation and protein aggregates in ALS...
  5. doi request reprint Protein aggregates and regional disease spread in ALS is reminiscent of prion-like pathogenesis
    Ashok Verma
    Department of Neurology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Neurol India 61:107-10. 2013
    ..This brief review discusses the prion-related domains in TDP-43 and FUS and their implication in protein aggregate formation and disease spread in ALS...
  6. doi request reprint Induced pluripotent stem cells and promises of neuroregenerative medicine
    Ashok Verma
    University of Miami Miller School of Medicine, Miami, FL, USA
    Neurol India 59:555-7. 2011
    ..This brief review summarizes currently available stem cell platforms, with emphasis on cellular reprogramming and iPS technology and its application in disease modeling and cell replacement therapy in neurodegenerative diseases...
  7. ncbi request reprint Epidemiology and clinical features of HIV-1 associated neuropathies
    A Verma
    Department of Neurology, University of Miami School of Medicine and Jackson Memorial Hospital, Florida, USA
    J Peripher Nerv Syst 6:8-13. 2001
    ..Because HIV-1-associated neuropathies are diverse in their etiology and pathogenesis, a precise clinical diagnosis is required to formulate a rational therapeutic intervention...
  8. ncbi request reprint Opsoclonus-myoclonus syndrome following Epstein-Barr virus infection
    Ashok Verma
    Department of Neurology, University of Miami School of Medicine, FL 33136, USA
    Neurology 58:1131-2. 2002
  9. ncbi request reprint Isolated cerebral mucormycosis: report of a case and review of the literature
    Ashok Verma
    Department of Neurology, University of Miami School of Medicine, 1150 NW 14 Street, Suite 701, Miami, FL 33136, USA
    J Neurol Sci 240:65-9. 2006
    ..Early tissue diagnosis and the consequent surgical excision of the necrotic tissue and aggressive antifungal therapy might salvage life in this fatal condition...
  10. ncbi request reprint ALS syndrome in patients with HIV-1 infection
    Ashok Verma
    Department of Neurology, Kessenich Family MDA ALS Center, University of Miami Miller School of Medicine, 1150 NW 14 Street, Suite 701, Miami, FL 33136, USA
    J Neurol Sci 240:59-64. 2006
    ..During the last 20 years, at least 19 cases of ALS or ALS-like disease have been reported in HIV-1 (HIV) seropositive individuals...
  11. ncbi request reprint Neuropathic scapuloperoneal syndrome (Davidenkow's syndrome) with chromosome 17p11.2 deletion
    Ashok Verma
    Department of Neurology, University of Miami Miller School of Medicine, Florida 33136, USA
    Muscle Nerve 32:668-71. 2005
    ..This observation suggests that the rare Davidenkow's syndrome is clinically related to HNPP and its genotype could be a chromosome 17p11.2 deletion...
  12. ncbi request reprint Bilateral basal ganglionic hemorrhage
    Ashok Verma
    Arch Neurol 63:464. 2006
  13. doi request reprint The ALS Nutrition/NIPPV Study: design, feasibility, and initial results
    Edward J Kasarskis
    Department of Neurology, University of Kentucky, Lexington, Kentucky, USA
    Amyotroph Lateral Scler 12:17-25. 2011
    ..The results of this study will allow us to model equations to predict the energy requirements in ALS and to plan a study of early intervention with NIPPV...
  14. doi request reprint Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect
    Erik P Pioro
    Section of ALS and Related Disorders, Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Ann Neurol 68:693-702. 2010
    ..To evaluate dextromethorphan combined with ultra low-dose quinidine (DMq) for treating pseudobulbar affect (PBA) in patients with amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS)...
  15. pmc Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery
    Katrina Gwinn
    National Institute for Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America
    PLoS ONE 2:e1254. 2007
    ..This resource should facilitate genetic discoveries which we anticipate will ultimately provide a better understanding of the biological mechanisms of neurodegeneration in ALS...
  16. ncbi request reprint Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis
    Merit E Cudkowicz
    Neurology Clinical Trials Unit, Massachusetts General Hospital, 13th Street, Charlestown, MA 02129, USA
    Muscle Nerve 38:837-44. 2008
    ..Arimoclomol CSF levels increased with dose. Arimoclomol was shown to be safe, and it crosses the blood-brain barrier. Serum pharmacokinetic profiles support dosing of three times per day. An efficacy study in ALS is planned...
  17. ncbi request reprint Recombinant tissue plasminogen activator in the treatment of intraventricular hemorrhage secondary to periventricular arteriovenous malformation before surgery: case report
    Krishna Kumar
    Department of Surgery, Section of Neurosurgery, Regina General Hospital, University of Saskatchewan, Regina, Saskatchewan, Canada
    Neurosurgery 52:964-8; discussion 968-9. 2003
    ....
  18. ncbi request reprint Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis
    Carlos Singer
    Mov Disord 22:289. 2007